Macquarie Group LTD Dr Reddys Laboratories LTD Transaction History
Macquarie Group LTD
- $80.3 Billion
- Q1 2025
A detailed history of Macquarie Group LTD transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Macquarie Group LTD holds 6,321 shares of RDY stock, worth $93,234. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,321
Previous 3,891
62.45%
Holding current value
$93,234
Previous $61,000
36.07%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RDY
# of Institutions
263Shares Held
98.8MCall Options Held
12.5KPut Options Held
800-
Robeco Institutional Asset Management B.V.10.7MShares$158 Million0.28% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny9.2MShares$136 Million0.19% of portfolio
-
Royal Bank Of Canada Toronto, A69.05MShares$133 Million0.03% of portfolio
-
Morgan Stanley New York, NY8.74MShares$129 Million0.01% of portfolio
-
Aikya Investment Management LTD London, X06.2MShares$91.5 Million30.32% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.45B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...